Cargando…
Application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with BMSC sheets for the treatment of infected bone defects in a rabbit model
BACKGROUND: The choice of bone substitutes for the treatment of infected bone defects (IBDs) has attracted the attention of surgeons for years. However, single-stage bioabsorbable materials that are used as carriers for antibiotic release, as well as scaffolds for BMSC sheets, need further explorati...
Autores principales: | , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185966/ https://www.ncbi.nlm.nih.gov/pubmed/35681160 http://dx.doi.org/10.1186/s12891-022-05499-z |
_version_ | 1784724836410458112 |
---|---|
author | Wang, Yanjun Zhao, Zihou Liu, Shiyu Luo, Wen Wang, Guoliang Zhu, Zhenfeng Ma, Qiong Liu, Yunyan Wang, Linhu Lu, Shuaikun Zhang, Yong Qian, Jixian Zhang, Yunfei |
author_facet | Wang, Yanjun Zhao, Zihou Liu, Shiyu Luo, Wen Wang, Guoliang Zhu, Zhenfeng Ma, Qiong Liu, Yunyan Wang, Linhu Lu, Shuaikun Zhang, Yong Qian, Jixian Zhang, Yunfei |
author_sort | Wang, Yanjun |
collection | PubMed |
description | BACKGROUND: The choice of bone substitutes for the treatment of infected bone defects (IBDs) has attracted the attention of surgeons for years. However, single-stage bioabsorbable materials that are used as carriers for antibiotic release, as well as scaffolds for BMSC sheets, need further exploration. Our study was designed to investigate the effect of vancomycin-loaded calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan (CSH/n-HA/CMCS) hydrogels combined with BMSC sheets as bone substitutes for the treatment of IBDs. METHODS: BMSCs were harvested and cultured into cell sheets. After the successful establishment of an animal model with chronic osteomyelitis, 48 New Zealand white rabbits were randomly divided into 4 groups. Animals in Group A were treated with thorough debridement as a control. Group B was treated with BMSC sheets. CSH/n-HA/CMCS hydrogels were implanted in the treatment of Group C, and Group D was treated with CSH/n-HA/CMCS+BMSC sheets. Gross observation and micro-CT 3D reconstruction were performed to assess the osteogenic and infection elimination abilities of the treatment materials. Histological staining (haematoxylin and eosin and Van Gieson) was used to observe inflammatory cell infiltration and the formation of collagen fibres at 4, 8, and 12 weeks after implantation. RESULTS: The bone defects of the control group were not repaired at 12 weeks, as chronic osteomyelitis was still observed. HE staining showed a large amount of inflammatory cell infiltration around the tissue, and VG staining showed no new collagen fibres formation. In the BMSC sheet group, although new bone formation was observed by gross observation and micro-CT scanning, infection was not effectively controlled due to unfilled cavities. Some neutrophils and only a small amount of collagen fibres could be observed. Both the hydrogel and hydrogel/BMSCs groups achieved satisfactory repair effects and infection control. Micro-CT 3D reconstruction at 4 weeks showed that the hydrogel/BMSC sheet group had higher reconstruction efficiency and better bone modelling with normal morphology. HE staining showed little aggregation of inflammatory cells, and VG staining showed a large number of new collagen fibres. CONCLUSIONS: Our preliminary results suggested that compared to a single material, the novel antibiotic-impregnated hydrogels acted as superior scaffolds for BMSC sheets and excellent antibiotic vectors against infection, which provided a basis for applying tissue engineering technology to the treatment of chronic osteomyelitis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05499-z. |
format | Online Article Text |
id | pubmed-9185966 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-91859662022-06-11 Application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with BMSC sheets for the treatment of infected bone defects in a rabbit model Wang, Yanjun Zhao, Zihou Liu, Shiyu Luo, Wen Wang, Guoliang Zhu, Zhenfeng Ma, Qiong Liu, Yunyan Wang, Linhu Lu, Shuaikun Zhang, Yong Qian, Jixian Zhang, Yunfei BMC Musculoskelet Disord Research BACKGROUND: The choice of bone substitutes for the treatment of infected bone defects (IBDs) has attracted the attention of surgeons for years. However, single-stage bioabsorbable materials that are used as carriers for antibiotic release, as well as scaffolds for BMSC sheets, need further exploration. Our study was designed to investigate the effect of vancomycin-loaded calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan (CSH/n-HA/CMCS) hydrogels combined with BMSC sheets as bone substitutes for the treatment of IBDs. METHODS: BMSCs were harvested and cultured into cell sheets. After the successful establishment of an animal model with chronic osteomyelitis, 48 New Zealand white rabbits were randomly divided into 4 groups. Animals in Group A were treated with thorough debridement as a control. Group B was treated with BMSC sheets. CSH/n-HA/CMCS hydrogels were implanted in the treatment of Group C, and Group D was treated with CSH/n-HA/CMCS+BMSC sheets. Gross observation and micro-CT 3D reconstruction were performed to assess the osteogenic and infection elimination abilities of the treatment materials. Histological staining (haematoxylin and eosin and Van Gieson) was used to observe inflammatory cell infiltration and the formation of collagen fibres at 4, 8, and 12 weeks after implantation. RESULTS: The bone defects of the control group were not repaired at 12 weeks, as chronic osteomyelitis was still observed. HE staining showed a large amount of inflammatory cell infiltration around the tissue, and VG staining showed no new collagen fibres formation. In the BMSC sheet group, although new bone formation was observed by gross observation and micro-CT scanning, infection was not effectively controlled due to unfilled cavities. Some neutrophils and only a small amount of collagen fibres could be observed. Both the hydrogel and hydrogel/BMSCs groups achieved satisfactory repair effects and infection control. Micro-CT 3D reconstruction at 4 weeks showed that the hydrogel/BMSC sheet group had higher reconstruction efficiency and better bone modelling with normal morphology. HE staining showed little aggregation of inflammatory cells, and VG staining showed a large number of new collagen fibres. CONCLUSIONS: Our preliminary results suggested that compared to a single material, the novel antibiotic-impregnated hydrogels acted as superior scaffolds for BMSC sheets and excellent antibiotic vectors against infection, which provided a basis for applying tissue engineering technology to the treatment of chronic osteomyelitis. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12891-022-05499-z. BioMed Central 2022-06-09 /pmc/articles/PMC9185966/ /pubmed/35681160 http://dx.doi.org/10.1186/s12891-022-05499-z Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Wang, Yanjun Zhao, Zihou Liu, Shiyu Luo, Wen Wang, Guoliang Zhu, Zhenfeng Ma, Qiong Liu, Yunyan Wang, Linhu Lu, Shuaikun Zhang, Yong Qian, Jixian Zhang, Yunfei Application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with BMSC sheets for the treatment of infected bone defects in a rabbit model |
title | Application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with BMSC sheets for the treatment of infected bone defects in a rabbit model |
title_full | Application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with BMSC sheets for the treatment of infected bone defects in a rabbit model |
title_fullStr | Application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with BMSC sheets for the treatment of infected bone defects in a rabbit model |
title_full_unstemmed | Application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with BMSC sheets for the treatment of infected bone defects in a rabbit model |
title_short | Application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with BMSC sheets for the treatment of infected bone defects in a rabbit model |
title_sort | application of vancomycin-impregnated calcium sulfate hemihydrate/nanohydroxyapatite/carboxymethyl chitosan injectable hydrogels combined with bmsc sheets for the treatment of infected bone defects in a rabbit model |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185966/ https://www.ncbi.nlm.nih.gov/pubmed/35681160 http://dx.doi.org/10.1186/s12891-022-05499-z |
work_keys_str_mv | AT wangyanjun applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT zhaozihou applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT liushiyu applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT luowen applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT wangguoliang applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT zhuzhenfeng applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT maqiong applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT liuyunyan applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT wanglinhu applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT lushuaikun applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT zhangyong applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT qianjixian applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel AT zhangyunfei applicationofvancomycinimpregnatedcalciumsulfatehemihydratenanohydroxyapatitecarboxymethylchitosaninjectablehydrogelscombinedwithbmscsheetsforthetreatmentofinfectedbonedefectsinarabbitmodel |